StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories nutritional Products Segment Total — Worldwide Revenue ($M) ($M)

Form 8-K Quarterly Earnings Releases (Item 2.02 Revenue Tables) & Form 10-K/10-Q MD&A

QuarterlyAnnual
Latest, FY2025
8,451
Period ended Dec 31, 2025
Change on a year earlier
+0.5%
8,413 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNutritional Products Segment Total — Worldwide Revenue ($M) ($M)Year on yearSource
FY2025Dec 31, 20258,451+0.5%SEC Filing (0001628280-26-002982) ↗
FY2024Dec 31, 20248,413+3.2%SEC Filing (0001628280-25-002092) ↗
FY2023Dec 31, 20238,154+9.3%SEC Filing (0001628280-24-002009) ↗
FY2022Dec 31, 20227,459-10.1%SEC Filing (0001628280-23-001516) ↗
FY2021Dec 31, 20218,294+8.5%SEC Filing (0001104659-22-007648) ↗
FY2020Dec 31, 20207,647+3.2%SEC Filing (0001104659-21-007942) ↗
FY2019Dec 31, 20197,409+2.5%SEC Filing (0001104659-20-005717) ↗
FY2018Dec 31, 20187,229+4.4%SEC Filing (0001104659-19-002848) ↗
FY2017Dec 31, 20176,925+0.4%SEC Filing (0001104659-18-003691) ↗
FY2016Dec 31, 20166,899-1.1%SEC Filing (0001104659-17-003920) ↗
FY2015Dec 31, 20156,975–SEC Filing (0001104659-16-091861) ↗

Breakdown

What makes up nutritional products segment total — worldwide revenue ($m)

Cite this data

StockData. (2026). Abbott Laboratories Nutritional Products Segment Total — Worldwide Revenue ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/nut-tot-rev-ww

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.